About

Theratechnica is a healthtech company pioneering the integration of AI, VR, and AR into clinical training and diagnostics. Founded in 2024 and headquartered in Greece with EU reach, we develop intelligent, immersive solutions that empower healthcare professionals and improve patient outcomes. Our core products include: 🔹 EarlyScan AI – an AI-powered diagnostic assistant for early pancreatic cancer detection 🔹 NurseTech VR – a virtual reality platform for realistic, hands-on nursing training 🔹 BiteTrack AI – an AI-based nutrition tracking app connecting patients with clinicians With a multidisciplinary team of clinicians, engineers, and strategists, Theratechnica addresses critical healthcare gaps — from early diagnosis to workforce upskilling — while fostering innovation “made in Greece” with global impact. Our mission: To make healthcare smarter, faster, and more human.

Solution & Product

Theratechnica develops an integrated suite of intelligent technologies that enhance clinical education, diagnostic accuracy, and patient engagement across the care continuum. Our core product lines include: 🔹 EarlyScan AI An AI-driven diagnostic assistant for early detection of pancreatic cancer, leveraging radiomics and clinical data to identify malignancy risks invisible to the human eye. Fully integrable with hospital PACS, it supports faster, more accurate diagnoses—especially in high-risk, asymptomatic patients. 🔹 NurseTech VR A comprehensive VR-based training platform for nursing professionals, simulating real-world hospital procedures in immersive environments. It reduces onboarding time, improves procedural accuracy, and supports scalable, competency-based education. 🔹 SurgiLite VR An advanced virtual reality simulation system for surgical training, offering realistic, hands-on experience with complex procedures. Built for both pre-clinical education and surgical upskilling, SurgiLite VR helps standardize training while lowering training-related risks and costs. 🔹 SurgiTech AR An augmented reality platform that assists surgeons in real time by overlaying critical anatomical and procedural information during operations. It enhances intraoperative precision and decision-making, supporting better outcomes and shorter learning curves. 🔹 BiteTrack AI A computer vision-based AI tool for personalized nutrition monitoring, connecting patients with dietitians and he

Innovation & Scalability

Theratechnica stands at the intersection of deep tech and clinical utility, offering a uniquely integrated approach to healthcare transformation through AI, VR, and AR. Our innovations are distinguished by: 🔹 Multi-modal Intelligence We combine imaging data, clinical history, and real-time decision support to address complex medical problems—such as early pancreatic cancer detection—with unmatched precision and explainability. 🔹 Immersive Learning Ecosystem From nursing to surgical practice, our VR and AR platforms provide lifelike, modular simulations that reduce training variability, accelerate onboarding, and support lifelong learning—fully aligned with institutional standards and regulatory pathways. 🔹 Built-in Interoperability All Theratechnica solutions are designed for seamless integration with hospital systems (PACS, EHRs), enabling plug-and-play scalability without disrupting existing workflows. 🔹 Regulatory-Aligned Architecture Developed under ISO 13485, ISO 14971, and IEC 62304 standards, our systems are CE-marking ready and MDR-compliant, facilitating rapid EU-wide expansion. Scalability Outlook: Geographic: Designed for deployment across EU markets, with localization pathways for multilingual, country-specific compliance. Technical: Modular architecture allows flexible integration across diverse care settings—from tertiary hospitals to training centers. Strategic: Our solutions support multiple verticals—diagnostics, education, prevention—offering bu

Traction & achievements

Since its founding in April 2024, Theratechnica has rapidly progressed from concept to market-ready solutions, demonstrating strong validation, clinical interest, and early commercial readiness. Key Milestones: 3 Ready-to-Market Products Developed • EarlyScan AI, NurseTech VR, and BiteTrack AI completed MVP, optimization, and pilot phases. • SurgiLite VR and SurgiTech AR in late-stage prototyping and validation. Pilot Implementations with Leading Clinical Institutions • Active collaborations with University General Hospital of Larissa and IASO Thessaly for validation and clinical feedback. • EarlyScan AI showed >96% sensitivity in retrospective diagnostic support for early pancreatic cancer detection. Pan-European Recognition & Participation • Selected for EIT Health InnoStars and actively engaged in EU-wide innovation programs. Revenue-Generating Product Pipeline • First revenue expected in Q3 2025. • Go-to-market strategy in place for broader EU launch through academic, hospital, and B2B partnerships. Team Growth & Brain Gain Impact • Built a cross-functional team of clinicians, engineers, and policy experts, with key roles repatriated from abroad—contributing to reversing brain drain.

Team & Why Us

Theratechnica brings together a uniquely qualified and mission-driven team with deep expertise in clinical medicine, immersive technologies, AI, and EU health innovation policy. Our complementary skill sets enable us to execute complex digital health solutions with both scientific rigor and strategic vision. Clinical & Scientific Leadership Prof. Dimitris Zacharoulis – Practicing surgeon and academic, ensures clinical relevance and pilot validation; led hospital-based deployment of NurseTech VR. Prof. George Stamoulis & Prof. George Floros – Renowned experts in electrical engineering and simulation technologies, leading Theratechnica’s VR/AR system architecture. Prof. Konstantinos Kolomvatsos – AI Advisor specializing in real-time machine learning, powering EarlyScan AI and other decision-support engines. Strategic & Operational Leadership Georgios Kouvidis, CEO – Former EU policy advisor with 20+ years in public finance and innovation governance. Drives regulatory strategy, funding, and EU-wide scaling. Vassiliki Tsita, COO – Economist with expertise in healthcare operations and compliance, overseeing MDR readiness, quality systems, and infrastructure. Why Us Proven execution across clinical pilots, regulatory alignment, and product launches Direct access to academic hospitals and public health networks in EU Real-world expertise at the intersection of healthcare, tech, and policy Strong alignment with EIT Health, Horizon Europe, and MDR framewo

Funding Needs

Theratechnica is currently seeking €1,000,000 in seed funding to accelerate clinical validation, regulatory preparation, and market launch of its flagship products across the European healthcare ecosystem. Use of Funds: Clinical Trials & Validation (30%) • Prospective clinical studies for EarlyScan AI (Q3 2025 launch target) • Expansion of NurseTech VR pilot programs across hospitals in the EU Regulatory & Quality Management (20%) • CE certification, ISO 13485 implementation, and MDR compliance • Early FDA pathway preparation (US market roadmap) Technology Development (30%) • Final engineering and scalability enhancements for SurgiLite VR and SurgiTech AR • Continuous AI optimization via anonymized clinical datasets Market Access & Business Development (15%) • Go-to-market campaigns and institutional onboarding • Strategic hiring in EU sales, clinical partnerships, and reimbursement policy Operational & Legal (5%) • Company infrastructure, IP protection, and data governance setup Co-Funding & Revenue Outlook: Actively pursuing non-dilutive grants through EU and EIT programs First equity round structured for smart capital aligned with long-term EU healthtech growth